FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

July 31 2018 A class 3 recall for sodium cromoglicate 2% w/v eye drops and Murine Hayfever Relief...

Effect of omega-3 on heart disease is negligible, finds Cochrane review

Effect of omega-3 on heart disease is negligible, finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

BLF highlights decline in stop smoking prescriptions

BLF highlights decline in stop smoking prescriptions

July 18 2018 There has been a 75% decline in stop smoking treatments being prescribed by GPs and...

Welsh National Survey includes OTC medicine purchases for first time

Welsh National Survey includes OTC medicine purchases for first time

June 28 2018 Over half the population in Wales has reported having bought an over the counter...

Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

  • FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    Tuesday, 31 July 2018 15:24
  • Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Thursday, 19 July 2018 10:21
  • BLF highlights decline in stop smoking prescriptions

    BLF highlights decline in stop smoking prescriptions

    Wednesday, 18 July 2018 17:32
  • Welsh National Survey includes OTC medicine purchases for first time

    Welsh National Survey includes OTC medicine purchases for first time

    Thursday, 28 June 2018 16:55
  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

parliament MPsJune 13 2014
APPG to draw up position statement for pharmacy
MPs and other parliamentarians have met to debate the value of e-cigarettes in healthcare, and their possible supply via pharmacy.

Following a meeting at Westminster on June 10, a position statement on e-cigarettes is to be drawn up and agreed, with the aim of setting out how the products can best be used to reduce smoking.
A number of parliamentary All-Party Groups (with interests in pharmacy, smoking and health, cancer, and heart disease) heard views on how e-cigarettes compare to tobacco products in terms of health risks.

The round table debate looked at whether e-cigarettes have a role in reducing the use and uptake of tobacco products, or are a potential "route to nicotine addiction for a new generation". It also considered whether e-cigarettes should be licensed as medicines and only available in healthcare settings such as pharmacies.

All Party Pharmacy Group chairman, Sir Kevin Barron MP said the meeting had been "hugely informative, and the discussion useful for informing Parliament on the debate around e-cigarettes.

"What’s clear is that e-cigarettes have the potential to play a major role in helping people to quit smoking," he said. "However, for that potential to be realised we need to be clear about how safe they are, and that they must not be allowed to create a gateway to nicotine addiction for a whole new generation of young people."

The All Party Groups are now being invited to agree a position statement on e-cigarettes. "We will then engage with Government and others to make sure the potential of these products to reduce smoking is realised,” said Sir Kevin.

Link:

All-Party Pharmacy Group

OTC News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...